Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alexion Pharmaceuticals, Inc. (ALXN)

« Back to company index

ALXN Chatter Timeline

Stock Ticker for ALXN

Most Active Tweeters for ALXN

UserTweets
@EnixBlockchain 12
@Gambiste1 10
@Tickeron 10
@bs_marker 8
@fezziwig2019 8

Recent Tweets for ALXN

WeekHerald @WeekHerald
$2.57 EPS Expected for Alexion Pharmaceuticals, Inc. $ALXN This Quarter https://t.co/ai4VIvnkYO
January 17th 2020, 1:01pm
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate Alexion Pharmaceuticals, Inc. $ALXN to Announce $2.57 EPS https://t.co/hoYIDBLR2z #stocks
January 17th 2020, 1:01pm
OlympiaReport @OlympiaReport
Zacks: Analysts Anticipate Alexion Pharmaceuticals, Inc. $ALXN to Announce $2.57 EPS https://t.co/74zEIB5PXg
January 17th 2020, 1:01pm
SwingTradeBot @SwingTradeBot
Rose Above Upper Bollinger Band today: $ALXN ... https://t.co/AyIukUGmib
January 17th 2020, 12:01pm
EnixBlockchain @EnixBlockchain
Agnes projected $ALXN would out-perform the NASDAQ, it outperformed the NASDAQ by 1.58%, Did you outperform the NAS… https://t.co/nx814SAbXp
January 17th 2020, 12:01pm
AmericanBanking @AmericanBanking
Alexion Pharmaceuticals $ALXN Price Target Raised to $131.00 at Morgan Stanley https://t.co/XZjo0Cssx2 #stocks
January 17th 2020, 9:01am
AmericanBanking @AmericanBanking
Jefferies Financial Group Weighs in on Alexion Pharmaceuticals, Inc.’s Q4 2019 Earnings $ALXN https://t.co/fFtHcrirQv #stocks
January 17th 2020, 8:01am
dispatchtribune @dispatchtribune
Jefferies Financial Group Weighs in on Alexion Pharmaceuticals, Inc.’s Q4 2019 Earnings $ALXN https://t.co/7wWv1yit4p
January 17th 2020, 8:01am
OlympiaReport @OlympiaReport
Alexion Pharmaceuticals, Inc. $ALXN Expected to Post Q4 2019 Earnings of $2.58 Per Share https://t.co/sabAZoPL7r
January 17th 2020, 8:01am
TranscriptDaily @TranscriptDaily
Alexion Pharmaceuticals $ALXN PT Raised to $131.00 at Morgan Stanley https://t.co/yJARqmK3PV
January 17th 2020, 8:01am
stocknewstimes @stocknewstimes
Alexion Pharmaceuticals $ALXN PT Raised to $131.00 at Morgan Stanley https://t.co/UD1c3oIedX
January 17th 2020, 8:01am
otcdynamics @otcdynamics
$ALXN Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020 https://t.co/WHHliHxJ1g
January 17th 2020, 7:01am
bbnsnews @bbnsnews
Alexion Pharmaceuticals $ALXN PT Raised to at Raymond James https://t.co/5LmqX6Qy49
January 17th 2020, 6:01am
stocknewstimes @stocknewstimes
Alexion Pharmaceuticals $ALXN Earns Outperform Rating from Wedbush https://t.co/jOLUaH0qQy
January 17th 2020, 6:01am
TranscriptDaily @TranscriptDaily
Alexion Pharmaceuticals’ $ALXN Buy Rating Reiterated at William Blair https://t.co/Irg1jx4jsb
January 17th 2020, 6:01am
odibro @odibro
$ALXN to Report 4Q and Full Year 2019 Results on Thursday, January 30, 2020 8AM
January 17th 2020, 6:01am
ThisLincolnian @ThisLincolnian
Alexion Pharmaceuticals $ALXN Rating Increased to Hold at BidaskClub https://t.co/SETJkljrRZ
January 17th 2020, 4:01am
ZolmaxNews @ZolmaxNews
FY2019 EPS Estimates for Alexion Pharmaceuticals, Inc. Raised by Analyst $ALXN https://t.co/WXayo5Jcdr
January 17th 2020, 1:01am
TickerReport @TickerReport
FY2019 EPS Estimates for Alexion Pharmaceuticals, Inc. Raised by Analyst $ALXN https://t.co/NBEdU3wahp
January 17th 2020, 1:01am
dailypoliticaln @dailypoliticaln
Alexion Pharmaceuticals $ALXN Given New Price Target at Raymond James https://t.co/nGLBRW9LE9
January 16th 2020, 5:01pm
ConsumerFeed @ConsumerFeed
Alexion Pharmaceuticals $ALXN Price Target Raised to https://t.co/L9iZBbcUqj
January 16th 2020, 5:01pm
TranscriptDaily @TranscriptDaily
Alexion Pharmaceuticals $ALXN Upgraded to “Hold” at BidaskClub https://t.co/nI05oiXWi4
January 16th 2020, 1:01pm
EnixBlockchain @EnixBlockchain
Agnes projected $ALXN would out-perform the NASDAQ, it outperformed the NASDAQ by 1.58%, Did you outperform the NAS… https://t.co/Uq3CTLVkNf
January 16th 2020, 12:01pm
dailypoliticaln @dailypoliticaln
Alexion Pharmaceuticals $ALXN Stock Rating Reaffirmed by William Blair https://t.co/5q0TufyBh9
January 16th 2020, 11:01am
WatchlistN @WatchlistN
William Blair Reaffirms “Buy” Rating for Alexion Pharmaceuticals $ALXN https://t.co/A3DOAeejtp
January 16th 2020, 11:01am
dakotafinancial @dakotafinancial
Alexion Pharmaceuticals $ALXN Earns Outperform Rating from Wedbush https://t.co/JVwtlV01Qo
January 16th 2020, 9:01am
TheMarketsDaily @TheMarketsDaily
Alexion Pharmaceuticals $ALXN Given Outperform Rating at Wedbush https://t.co/7WX789nnsQ
January 16th 2020, 9:01am
JamesEKrause @JamesEKrause
$ACHN $ALXN HSR filings for merger agreement. The 30-calendar-day waiting period is scheduled to expire at 11:59… https://t.co/wuL0gZ91Gp
January 16th 2020, 8:01am
AmericanBanking @AmericanBanking
Alexion Pharmaceuticals, Inc. $ALXN to Post FY2019 Earnings of $9.73 Per Share, Jefferies Financial Group Forecasts… https://t.co/DVOblZkyzD
January 16th 2020, 6:01am
bbnsnews @bbnsnews
Alexion Pharmaceuticals, Inc. $ALXN to Post FY2019 Earnings of $9.73 Per Share, Jefferies Financial Group Forecasts https://t.co/EYqT9qFnGC
January 16th 2020, 6:01am
Investor666 @Investor666
$ALXN to Start Pivotal Study on Ultomiris for ALS in Q1 https://t.co/eBOqc5aN6f via @YahooFinance
January 16th 2020, 5:01am
AmericanBanking @AmericanBanking
Raymond James Boosts Alexion Pharmaceuticals $ALXN Price Target to https://t.co/nLpm1X21se #stocks
January 15th 2020, 4:01pm
TheMarketsDaily @TheMarketsDaily
Alexion Pharmaceuticals $ALXN PT Raised to at Raymond James https://t.co/XIwl2Aswof
January 15th 2020, 4:01pm
dakotafinancial @dakotafinancial
Alexion Pharmaceuticals $ALXN PT Raised to at Raymond James https://t.co/XC9bwTeRLu
January 15th 2020, 4:01pm
SeekingAlpha @SeekingAlpha
$ALXN - Alexion Pharmaceuticals (ALXN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow. Read… https://t.co/P9WVU8pLBb
January 15th 2020, 3:01pm
BlueBioNow @BlueBioNow
$ALXN substantial stock price changes -2.13 % change recently https://t.co/5LmH8YLvlK
January 15th 2020, 12:01pm
ConsumerFeed @ConsumerFeed
Alexion Pharmaceuticals $ALXN Receives Buy Rating from William Blair https://t.co/6I6lwv0htj
January 15th 2020, 12:01pm
OlympiaReport @OlympiaReport
William Blair Reiterates Buy Rating for Alexion Pharmaceuticals $ALXN https://t.co/S5Sc3ZiTZm
January 15th 2020, 12:01pm
EnixBlockchain @EnixBlockchain
Agnes projected $ALXN would out-perform the NASDAQ, it outperformed the NASDAQ by 2.73%, Did you outperform the NAS… https://t.co/byap6PBSzi
January 15th 2020, 12:01pm
brendan_49 @brendan_49
@WexCapital @Sanctuary_Bio I do predict that $ALXN acquires more C3-like inhibitors, though. $NGM was able to devel… https://t.co/FeVnzazh4V
January 15th 2020, 11:01am
fezziwig2019 @fezziwig2019
@bio_clouseau $ALXN Ultomiris-Like Soliris- pts lost HgB while $APLS APL-2 pts Gained - isn’t that the goal of therapy?
January 15th 2020, 11:01am
Gambiste1 @Gambiste1
RT @BosBizAllison: Insight from #JPM20: @AlexionPharma executives address competitors with plans to more than double $ALXN ’s product portf…
January 15th 2020, 10:01am
BosBizAllison @BosBizAllison
Insight from #JPM20: @AlexionPharma executives address competitors with plans to more than double $ALXN ’s product… https://t.co/vBFPDkf4ZB
January 15th 2020, 10:01am
brendan_49 @brendan_49
Maybe $ALXN went straight to pivotal trial in ALS because if instead they achieved PoC they worry $APLS would immed… https://t.co/Ld268XNlUB
January 15th 2020, 9:01am
Quantumup1 @Quantumup1
Raymond James raises PT for $ALXN to $162, maintains an Outperform rating https://t.co/4Kwwl2WJYz
January 15th 2020, 7:01am
TickerReport @TickerReport
Alexion Pharmaceuticals $ALXN Rating Reiterated by Wedbush https://t.co/V8sJR3cLxp
January 15th 2020, 5:01am
bbnsnews @bbnsnews
Alexion Pharmaceuticals $ALXN Given “Outperform” Rating at Wedbush https://t.co/gOA4tJ3iHT
January 15th 2020, 5:01am
ZolmaxNews @ZolmaxNews
Alexion Pharmaceuticals $ALXN Upgraded to Hold at BidaskClub https://t.co/Yg2GVxfe1s
January 15th 2020, 2:01am
DZalkowitz @DZalkowitz
@biotechhack Not all is rosey. $ALXN did a bad deal with $MITO as trial failed post equity investment/ partnership… https://t.co/xqGVgwJxVl
January 15th 2020, 1:01am
DhiaJafar @DhiaJafar
$ALXN Hantson said Tuesday that the firm’s (Elliot)recommendation that Alexion pursue a sale resulted in rumors tha… https://t.co/nmxFpoL10W
January 15th 2020, 1:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.